Mitochondrial respiration/oxidative phosphorylation is the main source of energy, in the form of ATP, in the heart under physiological conditions. Different respiratory substrates were used in various experiments during heart perfusion: glucose, pyruvate, lactate, glucose + pyruvate, glucose + lactate, glucose + insulin etc. Also under physiological conditions, the concentration of respiratory substrates/hormones in blood can vary significantly. In the present study, we tested the effect of pyruvate, lactate and insulin (all in the presence of glucose) and glucose (in the presence of pyruvate) on the ATP-producing and -consuming blocks in perfused rat heart, in a system where HR (heart rate) was allowed to vary (no pacing). Changes in RPP (rate-pressure product) and PCr (phosphocreatine) concentration were measured. PAA (Proportional Activation Approach) was used to visualize and quantitatively analyse the data. It was demonstrated that addition of glucose (in the presence of pyruvate) exerted essentially no effect on the system. Insulin (in the presence of glucose) activated only the ATP producer. The most interesting finding is that, in our system, pyruvate and lactate (added in the presence or instead of glucose) activated ATP producer, but significantly inhibited ATP consumer (their effect was quantitatively identical).
INTRODUCTION
Oxidative phosphorylation in mitochondria is the main source of energy in the form of ATP in heart under physiological conditions. Different respiratory substrates can be used by the heart depending on their abundance in blood and on physiological conditions, for example glucose, pyruvate, lactate, fatty acids and ketone bodies. The level of insulin significantly affects the glucose uptake. Different combinations of these substrates/hormones were used as components of the perfusion medium in various experiments on perfused heart: glucose, pyruvate, lactate, GP (glucose + pyruvate), GL (glucose + lactate), GI (glucose + insulin) and so on [1] [2] [3] [4] [5] [6] [7] [8] . It has been shown [3] that pyruvate elevated RPP (ratepressure product) and [PCr] (phosphocreatine concentration) in the paced guinea-pig heart system. However, the effects of particular components on the oxidative phosphorylation system have not been systematically studied in the unpaced rat heart.
The energetic system of heart can be conceptually divided into two blocks: ATP production and ATP consumption, as is done within MoCA (Modular Control Analysis) [5, 6] or PAA (Proportional Activation Approach) [9, 10] . These blocks 'communicate' with each other only through a group of metabolites, the concentrations of which are uniquely related to each other: ATP, ADP, P i , PCr and Cr (creatine). In principle, each of these metabolites can be chosen as a representative of the entire group, but in practice it is convenient to choose PCr, because its concentration can be measured non-invasively by NMR and it can change significantly (unlike ATP concentration) under physiological conditions. Generally, changes in [PCr] involve implicitly changes in [Cr] , [ATP] , [ADP] and [P i ]. External effectors, such as Ca 2 + , are not one of the ways in which the PCrproducing block and PCr-consuming block communicate with each other. Heart activation/inactivation results in variations in work and ATP turnover flux that can be represented approximately by RPP. Generally, the recording of changes in RPP and [PCr] caused by some external factor enables discovery of whether the ATP producer and consumer are activated or inhibited by this factor, and to what extent [5, 10] .
It has been demonstrated that both elevated Ca 2+ in the perfusion medium [5] and adrenaline [10] activate the ATP producer and consumer to a similar level. However, it was also observed that, in unpaced heart, [PCr] is much higher in hearts perfused with pyruvate compared with glucose [5] . Nevertheless, few studies (see e.g. [3, 4, 11] ) have been conducted using the same beating hearts on the effect of replacing glucose with pyruvate or vice versa (or other changes of substrate/hormone composition of the perfusion medium). Respiratory substrates can be considered as an external effector as well as calcium ions or adrenaline. For instance, it was demonstrated that lactate/pyruvate added to a suspension of isolated hepatocytes activate both the (electrical potential across the mitochondrial inner membrane)-producing and the -consuming system, although the former was activated to a slightly greater extent [9] .
It has been demonstrated that PAA [9] is a very useful theoretical method for quantitative analysis of the proportional activation of the producer and consumer of some metabolite (group of metabolites) M by some external effector [9, 10] . In the present study, PAA was used to determine quantitatively the effect (activation or inhibition) on the ATP-producing and ATP-consuming system of the following changes in the substrate/hormone composition of the perfusion medium: (1) replacement of glucose with pyruvate (Gluc→Pyr transition); (2) addition of pyruvate in the presence of glucose (Gluc→GP transition); (3) addition of lactate in the presence of glucose (Gluc→GL transition); (4) addition of glucose in the presence of pyruvate (Pyr→GP transition); (5) addition of insulin in the presence of glucose (Gluc→GI transition). We hypothesize that the substrate/hormone composition of the perfusion medium has a significant effect on the kinetic properties of the bioenergetic system of the cardiac myocyte.
METHODS

Rat heart procedures
The investigation conforms to the National and European Research Council Guide for the care and use of laboratory animals. P. Diolez has been attributed a permanent licence to conduct experiments on animals by the service Vétérinaire de la Santé et de la Protection animale of the Ministère de l'Agriculture et de la Forêt (03/17/1999).
Langendorf perfusion and NMR measurements procedures for perfused rat (Male Sprague-Dawley: 350-400 g body weight) heart were described previously in [6] . Rats were anaesthetized with 40 mg of pentobarbital injected intraperitoneally. The thorax was opened and hearts were rapidly excised, and immediately cooled in ice-cold Krebs-Henseleit buffer, used as ice-cold physiological solution. Hearts were perfused by an aortic canula at constant pressure (100 mmHg) with Krebs-Henseleit solution (95 % O 2 and 5 % CO 2 , pH 7.35, temperature 37
• C) containing 10 mmol/l sodium pyruvate as substrate and actual free calcium concentration set to 2.0 mmol/l. LVP (left ventricle systolic pressure) of unpaced heart was measured under isovolumic conditions of contraction made possible by a latex balloon inserted into the left ventricle and connected to a pressure transducer. Mechanical performance was evaluated as the product of heart frequency and developed pressure (RPP, in mmHg · min −1 · beat). Generally, we used the unpaced heart system. This differs from some other perfusion systems where pacing was applied [3, 4] . To study the effects of external parameters under physiological conditions, pacing was not applied.
Perfused heart was placed into a 20-mm-diameter NMR tube inserted into a 9.4-T super-conducting magnet equipped with a 20 mm bore (Bruker DPX400 Avance) for 31 P-NMR spectroscopy. In order to eliminate endogenous substrates and remaining anaesthetics, at least 20 min were allowed for stabilization of heart activity before any measurement was made.
For the study of steady-state modifications, four NMR spectra (5 min duration time for each spectrum) were acquired before modulation was applied, then after a transition time equivalent to one spectrum (5 min), four new spectra (20 min) were recorded. Each steady state (before and after modulation) was characterized by the mean values of the four spectra for phosphorylated compounds and the corresponding four RPP values.
The effects of the following changes in the substrate/hormone composition of the perfusion medium were studied: (1) Gluc→Pyr transition; 16.7 mM of glucose was replaced with 10 mM of pyruvate; (2) Gluc→GP transition; 10 mM of pyruvate was added to 16.7 mM of glucose; (3) Gluc→GL transition; 20 mM of lactate was added to 16.7 mM of glucose; (4) Pyr→GP transition; 16.7 mM of glucose was added to 10 mM of pyruvate; (5) Gluc→GI transition; 20 i.u. of insulin was added to 16.7 mM of glucose.
The elasticity of the ATP/PCr producer to PCr can be determined by a direct change of the activity of the consumer. This causes a change in [PCr] , which affects the flux through the producer. The elasticity of the ATP/PCr consumer to PCr can be determined in the opposite way. To perform this kind of analysis, one must use agents that directly increase/decrease (modulate) the activity of the consumer and at the same time have no effect on the activity of the producer or vice versa.
NaCN, an inhibitor of cytochrome oxidase, was used to directly decrease the activity of the ATP/PCr producer. The linearity of the response of the consumer to PCr for glucose as the respiratory substrate was tested by applying three different NaCN concentrations, namely 0.1, 0.2 and 0.3 mM. The results obtained confirmed the assumption concerning the linearity (see Figures 2,  3 and 4 and the Discussion below). The response of the ATP producer to PCr, measured by an increase in the balloon volume in the left ventricle (direct activation of the ATP/PCr consumer), was calculated from averaged relative changes in RPP and [PCr] given in Table 2 in [5] , an experiment carried out with the same substrate (glucose), rat breed and conditions as used in the present experiment. The linearity of the response of the ATP/PCr producer to PCr was confirmed in [10] by applying both an increase in the balloon volume in the left ventricle (activation of the consumer) and BDM (butane-2,3-dione monoxime) administration (inhibition of the consumer) (see the Discussion below). The elasticities of the producer and consumer were calculated as the ratios of the relative changes in RPP to the relative changes in [PCr] [( RPP/RPP)/( PCr/PCr)] after an increase in the balloon volume and after NaCN administration respectively.
Technically, the measurements of the producer and consumer elasticities to PCr, and of the responses to an external effector, must be performed on different hearts.
Theoretical methods
The PAA [9] was used in the present work to analyse, interpret and visualize the experimental data. PAA defines the proportional activation coefficient as the ratio of the relative direct activation by some factor F (it may be e.g. hormone, electrical/neural stimulation or respiratory substrate) of the consumer (C) of some metabolite M (for instance PCr or ATP) to the relative direct activation of the producer (P): ( C/C)/( P/P) [9] . It was shown [9] that this coefficient (P PC F ) can be derived as follows:
where ε
are elasticities of the consumer and producer to M respectively, and τ is the response of the system to the factor F, defined as the relative change in the metabolite concentration divided by the relative change in flux (J):
The values of the elasticities (defined within the so-called Metabolic Control Analysis: see, e.g., [12] for a review) of the M producer and M consumer blocks to [M] (ε P M and ε C M respectively) quantify the relative change in the flux through these blocks in response to a given relative change in [M] . The higher the absolute value of the elasticity, the more sensitive is the flux to changes in [M] . In principle, elasticities are defined as infinitesimal coefficients, but when the responses of fluxes to M are (nearly) linear, as takes place in our system, they can be identified with large-scale responses of the producer and consumer blocks to [M] . Under typical conditions, ε P M is negative (M inhibits its own production), whereas ε C M is positive (M activates its own consumption).
All possible cases of the effect of some external factor on the system of production and consumption of some metabolite (group of metabolites) M are presented in When the effect overlaps with the elasticity of the consumer to M (ε C ), only the producer is activated/inhibited. When the effect overlaps with the elasticity of the producer to M (ε P ), only the consumer is activated/inhibited. When the effect lies somewhere between ε C and ε P , both producer and consumer are affected (activated or inhibited), as indicated in the Figure. or inhibited. In the special case when τ = 0 (no changes in M; horizontal line in Figure 1 ), both P and C are directly activated or inhibited to the same extent (P PC F = 1). In all other cases, both C and P are activated and/or inhibited to the relative extent characterized by P PC F , as indicated in Figure 1 . In particular, when P PC F is positive, both P and C are either activated or inhibited, whereas if P PC F is negative, P is activated and C is inhibited or vice versa. In the present work, PAA was used to determine quantitatively the respective direct activation or inhibition of the ATP producer and ATP consumer blocks as the result of changes in the substrate/hormone composition of the perfusion medium, as indicated above.
Statistics and calculations
Results are presented as means + − S.D. The effects of changes in the substrate/hormone composition of the perfusion medium were compared using one-way ANOVA. Significant differences were considered at P < 0.05. P PC F coefficients were calculated in the following steps. For each particular heart, the values of RPP and [PCr] for control and modified substrate/hormone composition were used for calculation of the relative change in RPP and [PCr] during a given transition. The responses, τ , were calculated as indicated above. Proportional activation coefficients were calculated from the responses and elasticities according to eqn. 1 (using the values of the elasticities of the producer and consumer to [PCr], equal to − 5.34 and 0.96 respectively, determined as described above). Using this method, only RPP and [PCr] and relative changes in these variables can be presented as means + − S.D.
RESULTS AND DISCUSSION
Effect of pyruvate, lactate and insulin
In the present study, we measured HR (heart rate), LVP and thus RPP, as well as [PCr] in the same hearts in control conditions (with glucose as the respiratory substrate) and after a given transition (modification of the substrate/hormone composition in the perfusion medium). The results of these measurements for different transitions are presented in Tables 1 and 2 . The results in Table 1 show that pyruvate, lactate and insulin caused statistically significant changes in both RPP and [PCr]. Pyruvate and lactate decreased RPP, whereas insulin increased this variable. In all cases, a significant increase in [PCr] was observed. As to the components of RPP, both HR and LVP were affected, although the effect on LVP seems to be generally greater than on HR (Table 2) . Averaged relative changes in RPP and [PCr] were used for calculation of the responses, τ , of the system to modifications of substrate/hormone composition, and subsequently for calculation of proportional activation coefficients (Table 3) .
The values of RPP and [PCr] for control conditions (with glucose) were used as reference values and scaled for 100 % for each transition. This is what 100 % (the 'reference point') means in Figures 2-4 . Scaling for 100 % is important, because it enables one to compare different experiments and the PAA deals with relative changes in fluxes and metabolite concentrations. The Table 3 . The data concerning the Gluc→GP and Gluc→Pyr transitions clearly demonstrated that, in our system, although pyruvate significantly activates the ATP producer, it also surprisingly significantly inhibits the ATP consumer. This can be seen in Figure 2 , where both transitions are directed up and left from the initial point (compare with Figure 1 ). The calculated P PC F coefficients equal − 0.307 and − 0.296 for the Gluc→GP transition and the Gluc→Pyr transition respectively. This means that, in both cases, the activation of the producer was approx. 3-fold higher than the inhibition of the consumer. It may seem paradoxical that, although the activation of the producer is approx. 3-fold greater than the inhibition of the consumer, the flux through the system decreases rather than increases. However, one should bear in mind that the consumer has a much greater (3.7-fold with glucose as the substrate) control over the flux than the producer [5] . The effect on the flux is proportional to the product of the relative activation/inhibition and the control over flux. For this reason, in our system the smaller relative inhibition of the consumer prevails over the much higher relative activation of the producer.
We tested both transitions, because, although we used either the glucose or pyruvate system in our previous studies [5] , the Gluc→Pyr transition comprises the combined effect of pyruvate addition and glucose removal. On the other hand, the Gluc→GP transition is equivalent to a pure effect of pyruvate addition. However, both transitions are similar, indicating that the effect of glucose removal (when pyruvate is added) is minor.
This conclusion is supported by the studies on the Pyr→GP transition, where no statistically significant effect on either RPP or [PCr] was observed (results not shown). This result strongly suggests that, in the presence of saturating concentrations of pyruvate, glucose has negligible influence on the kinetic properties of the system.
The effect of lactate (Gluc→GL transition) was very similar to that of pyruvate, although both metabolites exert opposite effect on the cytosolic NADH/NAD + ratio. This is demonstrated in Figure 3 . The calculated proportional activation coefficient P PC F for lactate equals − 0.310. Again, as in the case of pyruvate, this means that the inhibition of the consumer is approx. 3-fold smaller than the activation of the producer.
In the presence of glucose, insulin directly activates the ATP producer and has no direct effect on the ATP consumer. This is clearly seen in Figure 4 , where the Gluc→GI transition is presented. It is evident that the effect of insulin addition overlaps (within experimental error) with the consumer elasticity to PCr. Thus, the P PC F coefficient equals (approximately) zero (see Table 3 ). As shown in Figure 1 , this means a pure activation by insulin of the ATP producer without the inhibiting effect on the consumer observed with pyruvate and lactate. In fact, when the metabolic control is shared by both the producer and consumer, a direct activation of the producer only will cause an increase in [PCr] , which in turn indirectly activates the consumer and increases RPP. In such a case the slope of the response to some external effector (hormone, substrate) overlaps with the elasticity of the consumer to [PCr] , as can be seen in Figure 4 . In other words, this result simply means that the consumer is not activated directly, but only via the increase in [PCr] caused by the direct activation of the producer.
Generally, the results from the present study demonstrate that the substrate/hormone composition of the perfusion medium has pronounced impact on the kinetic properties of oxidative phosphorylation in perfused heart. 
Mechanism of pyruvate/lactate
The fact that pyruvate/lactate activates the ATP producer is something that could be expected, because, as a substrate of the tricarboxylic acid cycle, it accelerates NADH production in the mitochondrial matrix, elevates the mitochondrial NADH/NAD + ratio and thus activates oxidative phosphorylation through a faster electron supply to the respiratory chain. However, perhaps the most surprising finding of the present study is the significant inhibition of the ATP consumer by pyruvate and lactate. This inhibition has nothing to do with the cytosolic redox potential, because pyruvate, being the 'oxidized form of lactate', lowers, through lactate dehydrogenase, the cytosolic NADH/NAD + ratio, whereas lactate has the opposite effect. It is also unlikely that the inhibition of the consumer results from a decrease in the transient calcium concentration, because this would also inhibit the producer. Finally, pyruvate/lactate did not change the cytosolic pH (roughly estimated from the hardly seen P i peak in the NMR spectrum). Therefore, it is difficult to determine the mechanism responsible for the inhibition of the PCr consumer by pyruvate/lactate. We can only speculate that heart pacing, absent in our system, somehow prevents the inhibition of heart contractile activity by pyruvate/lactate (see below).
Our previous paper [5] and the present study demonstrate that, in our system, the PCr concentration in a heart perfused with pyruvate is much higher than in a heart perfused with glucose. Recently we speculated that, with pyruvate, the PCr/Cr ratio can even be as high as 10 [10] . However, these intuitive expectations are probably somewhat exaggerated: computer simulations using the computer model of oxidative phosphorylation in heart [13] suggest that the PCr/Cr ratio for pyruvate of approx. 2.5 would be able to account for our results (results not shown). The present study offers a reliable mechanism that could be responsible for the discussed phenomenon. Namely, both activation of ATP producer and inhibition of ATP consumer increases the PCr/Cr ratio. The concomitant action of these two effects is able to elevate the PCr/Cr ratio to very high levels.
Reasons for the lack of effect of glucose
The lack of significant effects on the system of the addition of glucose in the presence of high levels of pyruvate, shown in the present study, is not surprising. Glucose, as a substrate of glycolysis, produces just pyruvate. Continuous supply of pyruvate constitutes a metabolic 'short cut' -glycolysis is not needed any more and it can be inhibited (for instance by a high ATP/ADP ratio, linked to a high PCr/Cr ratio, or low P i and AMP concentration). As stated in [3] , in the presence of pyruvate "the numerous ratelimiting steps in glycolysis are avoided". It was suggested in [4] that glycolysis is self-limited at high fluxes by increasing the cytosolic NADH/NAD + ratio and thus blocking glyceraldehyde-3-phosphate dehydrogenase. Generally, in the presence of pyruvate, glucose loses its significance as a respiratory substrate.
Of course, glucose regains its importance in the absence of pyruvate and other respiratory substrates. In such a case, an increase of glucose supply will of course mean a significant activation of the ATP producer. This is most probably the reason why insulin accelerates ATP synthesis, without having any direct influence on ATP usage (Figure 4) . Namely, it is a well-known fact that one of the main functions of this hormone is to increase the glucose uptake by cells from blood. Indeed, it was observed that in isolated perfused heart, insulin elevates glucose utilization [7] . Even in our system, where glucose concentration in the perfusion medium is high, the effect of insulin is quite significant. Therefore, one could expect a stronger effect at lower, more physiological, glucose concentrations.
It is worth mentioning that the contribution of different substrates to ATP synthesis and oxygen consumption may change with workload. For instance, in the perfusion medium used in [11] (glucose + insulin, lactate, oleate), lactate and oleate predominated at low workload (with negligible contribution of glucose, in agreement with our results), whereas, after transition to high workload induced by adrenaline, lactate and glucose came to make the highest contribution. This suggests that, with adrenaline in the perfusate, glucose addition in the presence of pyruvate or lactate would have a significant effect in our experimental system.
Effect of pyruvate/lactate in other studies
It has previously been shown using PAA that, in an isolated hepatocyte system, a mixture of lactate and pyruvate activates both the -producing and -consuming block [9] . This finding differs from what we observe in the present study. However, one should bear in mind that the ATP-consuming system is completely different in beating heart and in liver. In particular, one of the most important ATP-using processes in liver is gluconeogenesis that is activated by its substrates, pyruvate and lactate. Additionally, gluconeogenesis is very sensitive to the ATP/ADP ratio [14] , unlike ATP usage in our system. Finally, hepatocytes are cells isolated from non-excitable tissue. This example demonstrates clearly that it makes little sense to compare the effect of the same factor (lactate/pyruvate) in completely different systems/conditions, and that different tissues may answer in a completely different way to such a factor.
It has been demonstrated by Zweier and Jacobus [3] that pyruvate, when compared with glucose, causes an increase in both [PCr] and RPP. A rough estimation by means of PAA using this effect and our elasticities of the producer and consumer to PCr leads to the conclusion that, in this case, pyruvate activated the producer, but did not have any effect on the consumer. Therefore, Zweier and Jacobus [3] did not obtain the inhibition of the consumer encountered in our present study. However, the perfusion systems used in both experiments were very different. In particular, in [3] , electrically paced guinea-pig hearts were used. In our opinion, this difference between [3] and our experiment would be mainly explained by this kind of stimulation. Moreover, we observed (P. Diolez, V. Deschodt-Arsac and G. Calmettes, unpublished work) that the kinetic properties could change in regard to the animal species (rat or guinea pigs).
Kobayashi and Neely [4] found that pyruvate and lactate had different effects on the bioenergetic system in perfused heart. However, again, the paced heart system was used.
A similar [PCr] (estimated from the ATP/ADP ratio) and RPP (but a significantly higher respiration rate) in hearts perfused with pyruvate in comparison with hearts perfused with glucose were encountered in [15] . These findings contradict our present study. The reason for this discrepancy is unclear. It may be the different [Ca 2+ ] in the perfusate: 1.2 mM in [9] and 2.0 mM in our study. In our previous study [5] , an increase in [Ca 2+ ] in the perfusate from 2.0 mM to 3.5 mM changed to some extent the quantitative properties of the system. This is demonstrated in Figure 5 , where results concerning the Gluc→Pyr transition for [Ca 2+ ]=3.5 mM extracted from [5] are presented. This Figure constitutes only a crude approximation, because the data for glucose and pyruvate were obtained for different hearts. Nevertheless, one can see that, in this case, RPP slightly increases, which means that the relative inhibition of the consumer is here smaller than for [Ca 2+ ]=2.0 mM (compare with Figure 1 ). Another possibility could be the fact that the ventricular pressure was imposed by a balloon in our experiment and by afterload in [15] .
The above comparison of the results of different studies performed on perfused heart in different experimental systems testifies that the properties of the bioenergetic system in heart depend significantly on the experimental conditions. Therefore, the extrapolation of such studies to physiological conditions must be done with caution.
Linearity of response
For the quantitative analysis performed using the PAA, it must be assumed that the response of the PCr producer and consumer to PCr is linear. In our previous study [10] , we demonstrated that the response of the producer is linear over a very wide range of PCr concentrations by using an increase in the balloon volume in the left ventricle that activates the consumer, and an administration of BDM that inhibits the consumer. The calculated elasticities of the producer to PCr were similar in both cases. In the present work we demonstrated the linearity of the response of the consumer to PCr by using three concentrations of NaCN, an inhibitor of the producer (see Figures 2, 3 and 4) . Therefore, the discussed assumption is correct. The inhibitory effect of pyruvate on the PCr consumer may seem puzzling, but it is a result of our experimental data obtained in our system and not of the theoretical method (PAA) used for the analysis of the data (as mentioned above, PAA applied to the data obtained in [3] shows no inhibition of the PCr producer by pyruvate in that system).
Mechanism of insulin effect
In our recent study [10] we demonstrated that adrenaline activates both ATP production and ATP consumption to a similar extent. We hypothesized that this parallel activation was related to an increase in the calcium transient. However, this mechanism cannot work for insulin, because in this case only the ATP/PCr producer is activated (see Figure 4 ). An increase in the calcium transient should cause an activation of both the producer and consumer. Therefore, it seems that the mechanisms of the action of adrenaline and insulin are completely different. This is not surprising, because the role of these hormones also seems to be different: adrenaline elevates the energy metabolism and heart work, whereas insulin only selectively increases the uptake by cardiomyocytes of one of the respiratory substrates: glucose. A similar reasoning holds for the action of pyruvate/lactate: the inhibition of the ATP/PCr consumer testifies that an increase in the calcium transient is not involved in the activation of the producer in this case.
Implications for control in health and disease
Our results clearly suggest that heart energetics in vivo is controlled not only by sympathetic/parasympathetic neural system and 'high-energy' hormones such as adrenaline, but also by the substrate composition of blood and the transport of substrates from blood to cardiac myocytes. In particular, pyruvate and lactate are used by the heart preferentially in relation to glucose, and activate NADH supply to the respiratory chain. The physiological relevance of the inhibition of the ATP consumption by pyruvate/lactate encountered in our unpaced system is not clear, because the heart in vivo is 'paced' by the sympathetic neural system and such inhibition is not seen in electrically paced perfused hearts. An increase in glucose content in blood (taking place, for example, in diabetes) by itself (at high levels of pyruvate/lactate) does not increase the glucose utilization by the heart. Glucose uptake from blood is also diminished at low levels of insulin, which also takes place in diabetes. This leads to the conclusion that the heart in diabetic individuals cannot use the excess of glucose as a preferential respiratory fuel and therefore contribute to a decrease in its concentration in blood. Perhaps this restriction could be overcome by lowering the pyruvate/lactate concentration in blood and/or increase in the adrenaline level.
Conclusion
In conclusion, in the present study we demonstrate that the substrate/hormone composition of the perfusion medium has a pronounced influence on the kinetic properties of oxidative phosphorylation in perfused mammalian heart. In our system, with no heart pacing, pyruvate and lactate activate the ATPproducing block, but at the same time they significantly inhibit the ATP-consuming block. Glucose exerts essentially no effect in the presence of high pyruvate concentrations. Insulin (in the presence of glucose) activates only the ATP producer, probably through stimulating glucose uptake from the perfusion medium. Generally, our data suggest that various hormones (adrenaline and insulin) have very different mechanisms of action. It would be interesting to study the combined effects of physiological modulators of cardiac energetics in healthy and pathological hearts. 
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